Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma
Investigators will evaluate prophylactic tocilizumab prior to treatment with teclistamab.
Source: pharmacytimes.com
Robert Rifkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert Rifkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Rifkin Today - Breaking & Trending Today
Preventing Adverse Events With Bispecific Antibodies in Myeloma in the Community Setting
Robert Rifkin, MD, medical oncologist and hematologist at Rocky Mountain Cancer Centers, shares insight into how the phase 2 Optec study of teclistamab administration in the outpatient setting could help achieve important health equity and quality goals.
Source: ajmc.com
Fighting rare cancers from rural area adds to struggle
Fighting cancer is a tough battle. Then, add to that struggle the fact that the diagnosis is a rare cancer and the patient lives in a rural area. How does that patient cope? Rare cancers...
Source: steamboatpilot.com